Page results
-
Watch our short patient information videos on dementia
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
-
UCLH has moved one step closer to carbon net zero emissions with the installation of six new mobile Entonox destructions units across our birthing centre and labour wards.
-
On Wednesday 29th March, governors Mick Goss and Fiona McLean arranged for governors to visit the National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square.
-
Dr Satyen Gohil specialises in treating patients with CLL and lymphoma and leads a number of clinical trials for these conditions.
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
Contact the Patient Advice and Liaison Service (PALS)
-
The bites, stings, and animal-related injury service at the Hospital for Tropical Diseases offers high-quality, specialised treatment, care, and expert advice to adult patients who have experienced animal or plant-related injuries.
-
Freedom of Information request
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment